Effect of Seasonal Variation on Relapse Rate in Patients With Relapsing-Remitting Multiple Sclerosis in Saudi Arabia

被引:1
|
作者
Makkawi, Seraj [1 ,2 ,3 ]
Aljabri, Ammar [1 ,2 ]
Bin Lajdam, Ghassan [1 ,2 ]
Albakistani, Ammar [1 ,2 ]
Aljohani, Abdulrahman [1 ,2 ]
Labban, Suhail [1 ,2 ]
Felemban, Razaz [1 ,2 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia
[2] King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia
[3] Minist Natl Guard Hlth Affairs, Dept Med, Jeddah, Saudi Arabia
来源
FRONTIERS IN NEUROLOGY | 2022年 / 13卷
关键词
multiple sclerosis; seasonal variation; vitamin D; relapse; neuroinflammation; ENVIRONMENTAL RISK-FACTORS; VITAMIN-D; EPIDEMIOLOGY; EXACERBATIONS; PATHOGENESIS; MELATONIN; SYMPTOMS; PATTERNS; SYSTEM;
D O I
10.3389/fneur.2022.862120
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) is becoming a global subject of study in which some demographic variations are thought to be correlated with its activity. Relapsing-remitting multiple sclerosis (RRMS) is the most common demyelinating disorder, characterized by periods of exacerbating attacks, followed by partial or complete remission. Several factors might play a role in disease progression and relapse frequency, such as vitamin D, ultraviolet B radiation, estrogen levels, smoking, obesity, and unhealthy lifestyles. In this study, we identified the relationship between seasonal variation and relapse rate and correlated the latter with sex, age, and vitamin D levels in patients with RRMS in Jeddah, Saudi Arabia. We retrospectively collected data from 182 RRMS patients between 2016 and 2021. A total of 219 relapses were documented in 106 patients (58.2 %). The relapse per patient ratio showed a sinusoidal pattern, peaking in January at a rate of 0.49 and troughed in June at a rate of 0.18. There was no difference in relapse rates between men and women (p =0.280). There was a significant negative correlation between vitamin D levels and relapse rate (r = -0.312, p =0.024). Therefore, the relapse rate was higher during the winter and was correlated with low vitamin D levels. However, relapses are likely multifactorial, and more population-based studies are needed to understand the role of environmental variables in MS exacerbation. A better understanding of this relationship will allow for improved treatment and possibly better prevention of relapse.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Fingolimod for Relapsing-Remitting Multiple Sclerosis: The Experience From Saudi Arabia
    Algahtani, Hussein
    Shirah, Bader
    Al Malik, Yaser
    Meftah, Ibraheem
    CLINICAL NEUROPHARMACOLOGY, 2020, 43 (02) : 35 - 38
  • [2] Natalizumab Treatment for Relapsing-Remitting Multiple Sclerosis: The Experience From Saudi Arabia
    Algahtani, Hussein
    Shirah, Bader
    Abobaker, Hind
    Alghanaim, Nebras
    Kamel, Fatemah
    CLINICAL NEUROPHARMACOLOGY, 2018, 41 (06) : 199 - 201
  • [3] Effect of relapse phenotype on the accumulation of disability in relapsing-remitting multiple sclerosis
    Stewart, T.
    Jokubaitis, V.
    Spelman, T.
    Havrdova, E.
    Horakova, D.
    Trojano, M.
    Izquierdo, G.
    Girard, M.
    Duquette, P.
    Prat, A.
    Lugaresi, A.
    Grammond, P.
    Grand'Maison, F.
    Sola, P.
    Hupperts, R.
    Petersen, T.
    Pucci, E.
    Bergamaschi, R.
    Boz, C.
    Oreja-Guevara, C.
    Lechner-Scott, J.
    Alroughani, R.
    Ramo, C.
    Van Pesch, V.
    Fernandez-Bolanos, R.
    Iuliano, G.
    Rio, M. E.
    Granella, F.
    Slee, M.
    Verheul, F.
    Spitaleri, D. L. A.
    Amato, M. P.
    Hodgkinson, S.
    McCombe, P.
    Cabrera-Gomez, J. A.
    Barnett, M.
    Flechter, S.
    Olascoaga, J.
    Vucic, S.
    Sanchez-Menoyo, J. L.
    Cristiano, E.
    Saladino, M. L.
    Moore, F.
    Gray, O.
    Shuey, N.
    Rozsa, C.
    Singhal, B.
    Shaw, C.
    Butzkueven, H.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 726 - 728
  • [4] Is Relapse Pattern Predictable in Relapsing-Remitting Multiple Sclerosis?
    Kirchhof, Danielle
    Gauthier, Susan
    Nealon, Nancy
    Blagovest, B.
    Vartanian, Timothy
    Perumal, Jai
    NEUROLOGY, 2013, 80
  • [5] Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab
    Craner, Matthew
    Al Malik, Yaser
    Babtain, Fawzi A.
    Alshamrani, Foziah
    Alkhawajah, Mona M.
    Alfugham, Nora
    Al-Yafeai, Rumaiza H.
    Aljarallah, Salman
    Makkawi, Seraj
    Qureshi, Shireen
    Ziehn, Marina
    Wahba, Hazem
    NEUROLOGY AND THERAPY, 2022, 11 (04) : 1457 - 1473
  • [6] Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab
    Matthew Craner
    Yaser Al Malik
    Fawzi A. Babtain
    Foziah Alshamrani
    Mona M. Alkhawajah
    Nora Alfugham
    Rumaiza H. Al-Yafeai
    Salman Aljarallah
    Seraj Makkawi
    Shireen Qureshi
    Marina Ziehn
    Hazem Wahba
    Neurology and Therapy, 2022, 11 : 1457 - 1473
  • [7] Serum prolactin level in patients with relapsing-remitting multiple sclerosis during relapse
    Moshirzadeh, Sasan
    Ghareghozli, Kourosh
    Harandi, Ali Amini
    Pakdaman, Hossien
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (04) : 622 - 623
  • [8] Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab
    Laursen, Julie Hejgaard
    Sondergaard, Helle Bach
    Sorensen, Per Soelberg
    Sellebjerg, Finn
    Oturai, Annette Bang
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 10 : 169 - 173
  • [9] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [10] Clinical and economic evaluations of natalizumab, rituximab, and ocrelizumab for the management of relapsing-remitting multiple sclerosis in Saudi Arabia
    Mansour A. Alharbi
    Fahad Aldosari
    Ahmed Hasan Althobaiti
    Faris M. Abdullah
    Salman Aljarallah
    Nuha M. Alkhawajah
    Miteb Alanazi
    Yazed AlRuthia
    BMC Health Services Research, 23